Please provide your email address to receive an email when new articles are posted on . Fewer clinical deterioration events were reported in patients receiving ravulizumab (9.3%) vs. placebo (16.9%).

The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration ...

A study conducted across seven hospitals within the Yale New Haven (Conn.) Health System found that Epic’s Deterioration Index underperformed compared to other early warning scores in detecting ...

Data on the relationship between behavioral disturbances in Alzheimer's disease (AD) and global clinical deterioration is still controversial. The purpose of this study was to explore potential ...

A trio of companies has introduced new advances in artificial intelligence designed to improve patient outcomes and reduce clinician burnout. RapidAI announced a new tool that helps front-line ...

New blood-based metabolomics test predicts asthma attacks up to five years ahead, helping identify high-risk patients before ...

Please provide your email address to receive an email when new articles are posted on . The combination improved pain symptom scores compared with chemotherapy alone. No statistically significant ...

A new study published in The Lancet Child & Adolescent Health journal suggests that parental or caregiver intuition may outperform some traditional early warning systems in identifying children at ...

Picture this: a digital watchdog, prowling through heaps of patient data, poised to raise the alarm at the slightest sign of trouble. Enter a guardian angel, in the guise of algorithms designed to ...

Study links exosomal microRNA to ventricular remodelling in heart failure. Discover how this biomarker could inform future ...